The expression of metalloproteinase-2, -9, and -14 and of tissue inhibitors-1 and-2 is developmentally modulated during osteogenesis in vitro, the mature osteoblastic phenotype expressing metalloproteinase-14

Journal of Bone and Mineral Research

Volumn 15, Issue 11, 2000, Pages 2154-2168

  Filanti, C ^a   Dickson, G R ^b   Di Martino, D ^a   Ulivi, V ^a   Sanguineti, C ^a   Romano, P ^a   Palermo, C ^a   Manduca, P ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Developmental modulation; In vitro osteogenesis; Metalloproteinases; Nodule morphogenesis; Tissue inhibitors of metalloproteinases

Indexed keywords

COLLAGENASE; METALLOPROTEINASE; OSTEOCALCIN; SIALOPROTEIN; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE REMODELING; CELL MATURATION; CORTICAL BONE; EXTRACELLULAR MATRIX; IN VITRO STUDY; MOLECULAR CLONING; MORPHOGENESIS; NONHUMAN; OSTEOBLAST; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT;

ANIMAL; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELLS, CULTURED; FLUORESCENT ANTIBODY TECHNIQUE; GELATINASE A; GELATINASE B; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IN SITU HYBRIDIZATION; MATRIX METALLOPROTEINASES; METALLOENDOPEPTIDASES; OSTEOBLASTS; OSTEOGENESIS; PHENOTYPE; RATS; SUPPORT, NON-U.S. GOV'T; TIBIA; TISSUE INHIBITOR-OF METALLOPROTEINASE-2; TISSUE-INHIBITOR OF METALLOPROTEINASE-1;

EID: 0033791732     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2000.15.11.2154     Document Type: Article

References (78)

1. Osteoblast and chondroblast differentiation
2. Osteoblast cells from rat long bone. I. Characterization of their differentiation in culture
3. Rat tibial osteoblasts III: Propagation in vitro is accompanied by enhancement of osteoblast phenotype
4. Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationship in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix
5. Cultured tibial rat osteoblasts: In vitro production and topography of osteonectin, biglycan and decorin
6. Proteolytic remodeling of extracellular matrix
7. Focalized proteolysis: Spatial and temporal regulation of extracellular matrix degradation at the cell surface
8. The matrix metalloproteinase-14 (MMP-14) gene is structurally distinct from other MMP genes and is co-expressed with the TIMP-2 gene during mouse embryogenesis
9. A matrix metalloproteinase expressed on the surface of invasive tumour cells
10. Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library
11. Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP
12. Matrix metalloproteinase-2 an intersistial collagenase
13. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity
14. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2)
15. Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13)
16. Plasma membrane-dependent activation of gelatinase A in human vascular endothelial cells
17. Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures
18. The TIMP2 membrane type 1 metalloproteinase 'receptor' regulates the concentration and efficient activation of progelatinase A
19. Interleukin-6 and its soluble receptor cause a marked induction of collagenase 3 expression in rat osteoblast cultures
20. Mouse osteoblasts synthesize collagenase in response to bone resorbing agents
21. Human osteoblasts in culture synthesize collagenase and other matrix metalloproteinases in response to osteotropic hormones and cytokines
22. Hormonal regulation of the production of collagenase and a collagenase inhibitor activity by rat osteogenic sarcoma cells
23. Transforming growth factor β1 inhibits collagenase 3 expression by transcriptional and post-transcriptional mechanisms in osteoblast cultures
24. Parathyroid hormone regulates the rat collagenase 3-promoter in osteoblastic cells through the cooperative interaction of the activator protein-1 site and the runt domain binding sequence
25. Regulation of interstitial collagenase expression and collagen degradation by retinoic acid in bone cells
26. Parathiroid hormone-induced resorption in fetal rat limb bones is associated with production of the metalloproteinases collagenase and gelatinase B
27. Recombinant human bone morphogenetic protein-2 stimulates osteoblast differentiation and suppresses matrix metalloproteinase-1 production in human bone cells isolated from mandibulae
28. Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: Association of MMP induction with bone resorption
29. Intermittent administration of parathyroid hormone (1-34) stimulates matrix metalloproteinase-9 (MMP-9) expression in rat long bone
30. Collagenase 3 is a target of Cbfal, a transcription factor of the runt gene family involved in bone formation
31. Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis
32. Collagenase-3 (MMP-13) is expressed by hyperthrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development
33. Expression of interstitial collagenase is restricted to skeletal tissue during mouse embryogenesis
34. Expression of interstitial collagenase during skeletal development of the mouse is restricted to osteoblast-like cells and hypertrophic chondrocytes
35. Stromelysin-1 (MMP-3) and stromelysin-2 (MMP-10) expression in developing human bone: Potential roles in skeletal development
36. Characterization of insulin-like growth factor-binding protein 5-degrading proteases produced throughout murine osteoblast differentiation
37. The synthesis of collagenase, gelatinase-A (72kDa) and -B (95 kDa), and timp-1 and-2 by human osteoblasts from normal and arthritic bone
38. Human osteoblasts in vitro secrete tissue inhibitor of metalloproteinases and gelatinase but not interstitial collagenase as major cellular products
39. Expression of metalloproteinases and tissue inhibitors of metalloproteinases in human osteoblast-like cells: Differentiation is associated with repression of metalloproteinase biosynthesis
40. Distribution of matrix metalloproteinases and their inhibitor, TIMP-1, in developing human osteophytic bone
41. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hyperthrophic chondrocytes
42. MT-MMP, the cell surface activation of proMMP-2 (pro-gelatinase A), is expressed with its substrate in mouse tissue during embryogenesis
43. Expression and localization of membrane type 1 of metalloproteinase in tooth tissues
44. ECM and cell surface proteolysis: Regulating cellular ecology
45. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3
46. Transmembrane/cytoplasmic domain-mediated membrane type 1 matrix metalloproteinase docking to invadopodia is required for cell invasion
47. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2
48. Human 72-kilodalton type IV collagenase forms a complex with tissue inhibitor of metalloproteinase designated TIMP-2
49. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase and activation of the enzyme with stromelysin
50. Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinase-2
51. The C-terminal domain of 72kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases
52. Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP)
53. Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP)
54. Domain structure of human 72-KDa gelatinase/type IV collagenase
55. Concavalin A produces a matrix-degrading phenotype in human fibroblasts
56. Synthetic peptide containing Arg-Gly-Asp inhibits bone formation and resorption in a mineralizing organ culture system of fetal rat parietal bones
57. Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells
58. Cooperative signaling by α5β1 and α4β1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin
59. The activation of pro-MMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form
60. Collagen-induced activation of 72, 000 type IV collagenase in normal and malignant fibroblastoid cells
61. Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression
62. Activation of MMP-2 by human GCT23 giant cell tumor cells induced by osteopontin, bone sialoprotein and GRGDSP peptides is RGD and cell shape change dependent
63. The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix
64. Anti-alpha 3 integrin antibody induces the activated form of matrix metalloprotease-2 (MMP-2) with concomitant stimulation of invasion through matrigel by human rhabdomyosarcoma cells
65. Expression of 92 kD type IV collagenase/gelatinase B in human osteoclasts
66. Thrombin induces the activation of progelatinase A in vascular endothelial cells
67. Release of biological activities from quiescent fibronectin by a conformational change and limited proteolysis by matrix metalloproteinases
68. Limited cleavage of extracellular matrix protein BM-40 by matrix metalloproteinases increases its affinity for collagens
69. Gelatinase A activity directly modulates melanoma cell adhesion and spreading
70. Fibronectin regulates calvarial osteoblasts differentiation
71. Differentiation of canalicular cell processes in bone cells by basement membrane matrix components: Regulation by discrete domains of laminin
72. Osteoblastic cells from rat long bone. II. Adhesion to substrata and integrin expression in primary and propagated cultures
73. Distribution of noncollagenous proteins in the matrix of adult human bone: Evidence of anatomic and functional heterogeneity
74. In vitro osteoblasts are induced to increase alkaline phosphatase synthesis and radio-labeled calcium incorporation by an homeopathic preparation
75. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues
76. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction
77. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover
78. Cloning and initial characterization of mouse meltrin β and analysis of expression of four metalloprotease-disintegrins in bone cells